Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc. (SRPT)

Market is closed
News
5 Stocks Insiders and Billionaires Are Crazy About

5 Stocks Insiders and Billionaires Are Crazy About

This article presents an overview of the 5 Stocks Insiders and Billionaires Are Crazy About. For a detailed overview of such stocks, read our article, 11 Stocks Insiders and Billionaires Are Crazy...

Keep Reading →

December 19th, 2023 - Hedge Funds News

10 Beaten Down Stocks Billionaires Are Crazy About

10 Beaten Down Stocks Billionaires Are Crazy About

In this article, we will take a look at the 10 beaten down stocks billionaires are crazy about.

Keep Reading →

December 12th, 2023 - Hedge Funds News

5 Best Upside Stocks To Buy Now

5 Best Upside Stocks To Buy Now

In this piece, we will take a look at the five best upside stocks to buy right now.

Keep Reading →

November 27th, 2023 - Hedge Funds News

13 Stocks Insiders are Buying Now

13 Stocks Insiders are Buying Now

With the end of 2023 now in sight, many can say with confidence that the much-dreaded recession everyone was talking about will not realize this year.

Keep Reading →

November 24th, 2023 - Hedge Funds News

Here’s What Bronte Capital Calls “Sarepta Risk” in the Context of Sarepta Therapeutics (SRPT)

Here’s What Bronte Capital Calls “Sarepta Risk” in the Context of Sarepta Therapeutics (SRPT)

Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

November 7th, 2023 - Hedge Fund Investor Letters News

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2023 Earnings Call Transcript

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2023 Earnings Call Transcript

Operator: Good afternoon and welcome to the Sarepta Therapeutics Third Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.

Keep Reading →

November 2nd, 2023 - News Transcripts

Analysts on Wall Street Lower Ratings for These 5 Stocks

Analysts on Wall Street Lower Ratings for These 5 Stocks

BofA Securities analyst Arnaud Lehmann recently adjusted the outlook for Ferguson plc (NYSE:FERG) by downgrading the stock from Neutral to Underperform.

Keep Reading →

November 1st, 2023 - Market Movers News

5 Best Long-term Stocks To Buy For High Returns

5 Best Long-term Stocks To Buy For High Returns

In this piece, we will take a look at the five best long term stocks to buy for high returns.

Keep Reading →

October 30th, 2023 - Hedge Funds News

Hedge Fund and Insider Trading News: George Soros, Ray Dalio, Ken Griffin, Daniel Och, EDL Capital, Rokos Capital Management, Precigen Inc (PGEN), Sigilon Therapeutics, Inc. (SGTX), and More

Hedge Fund and Insider Trading News: George Soros, Ray Dalio, Ken Griffin, Daniel Och, EDL Capital, Rokos Capital Management, Precigen Inc (PGEN), Sigilon Therapeutics, Inc. (SGTX), and More

George Soros has been branded as a bogeyman by the right wing for backing liberal causes around the globe.

Keep Reading →

August 17th, 2023 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Davidson Kempner Capital Management, Oaktree Capital Management, Solus Alternative Asset Management, Two Sigma Advisors, Sarepta Therapeutics Inc (SRPT), Domino's Pizza Inc (DPZ), and More

Hedge Fund and Insider Trading News: Davidson Kempner Capital Management, Oaktree Capital Management, Solus Alternative Asset Management, Two Sigma Advisors, Sarepta Therapeutics Inc (SRPT), Domino's Pizza Inc (DPZ), and More

U.S.

Keep Reading →

August 11th, 2023 - Hedge Funds Insider Trading

Insider Monkey Quarterly Strategy
+246.9% Insider Monkey Quarterly Strategy
+107.5% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
200%
100%
0
Subscribe Now

Returns since its inception in May 2014 (through Feb 16th, 2024)